Cubist Systematic Strategies, LLC Veracyte, Inc. Transaction History

Cubist Systematic Strategies, LLC

$14.3 Billion
Q2 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 33,946 shares of VCYT stock, worth $1.15 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

33,946

Previous 33,946 -0.0%

Holding current value

$1.15 Million

Previous $735,000 -0.0%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$18.86 - $23.55 $2.58 Million - $3.22 Million	-136,548 Reduced 80.09%	33,946 $735,000
Q1 2024 May 15, 2024	BUY	$21.0 - $29.1 $3.06 Million - $4.24 Million	145,579 Added 584.3%	170,494 $3.78 Million
Q4 2023 Feb 14, 2024	SELL	$19.72 - $28.68 $521,889 - $759,016	-26,465 Reduced 51.51%	24,915 $685,000
Q3 2023 Nov 14, 2023	SELL	$22.33 - $29.92 $2.08 Million - $2.78 Million	-93,072 Reduced 64.43%	51,380 $1.15 Million
Q2 2023 Aug 14, 2023	BUY	$20.96 - $26.99 $2.81 Million - $3.62 Million	134,177 Added 1305.86%	144,452 $3.68 Million
Q1 2023 May 15, 2023	SELL	$20.58 - $27.89 $3.67 Million - $4.97 Million	-178,335 Reduced 94.55%	10,275 $229,000
Q4 2022 Feb 14, 2023	BUY	$15.31 - $29.94 $249,399 - $487,722	16,290 Added 9.45%	188,610 $4.48 Million
Q3 2022 Nov 14, 2022	BUY	$16.58 - $27.9 $1.41 Million - $2.38 Million	85,131 Added 97.64%	172,320 $2.86 Million
Q2 2022 Aug 15, 2022	BUY	$15.45 - $29.52 $81,823 - $156,337	5,296 Added 6.47%	87,189 $1.74 Million
Q1 2022 May 16, 2022	BUY	$21.94 - $42.51 $1.8 Million - $3.48 Million	81,893 New	81,893 $2.26 Million
Q4 2021 Feb 14, 2022	SELL	$36.09 - $53.79 $1.23 Million - $1.84 Million	-34,127 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$35.62 - $52.97 $2.18 Million - $3.24 Million	-61,228 Reduced 64.21%	34,127 $1.59 Million
Q2 2021 Aug 16, 2021	BUY	$32.94 - $56.62 $986,585 - $1.7 Million	29,951 Added 45.79%	95,355 $3.81 Million
Q1 2021 May 17, 2021	SELL	$44.47 - $81.38 $2.59 Million - $4.74 Million	-58,234 Reduced 47.1%	65,404 $3.52 Million
Q4 2020 Feb 16, 2021	BUY	$32.49 - $61.88 $4.02 Million - $7.65 Million	123,638 New	123,638 $6.05 Million
Q3 2020 Nov 16, 2020	SELL	$26.73 - $35.67 $285,476 - $380,955	-10,680 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$19.49 - $28.11 $208,153 - $300,214	10,680 New	10,680 $277,000
Q1 2020 May 15, 2020	SELL	$16.13 - $30.17 $204,334 - $382,193	-12,668 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$20.78 - $29.99 $263,241 - $379,913	12,668 New	12,668 $354,000
Q3 2019 Nov 14, 2019	SELL	$23.87 - $30.93 $1.16 Million - $1.5 Million	-48,393 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$22.1 - $28.56 $294,372 - $380,419	13,320 Added 37.98%	48,393 $1.38 Million
Q1 2019 May 15, 2019	BUY	$12.0 - $25.76 $110,556 - $237,326	9,213 Added 35.63%	35,073 $878,000
Q4 2018 Feb 14, 2019	SELL	$9.15 - $14.85 $43,087 - $69,928	-4,709 Reduced 15.4%	25,860 $325,000
Q3 2018 Nov 14, 2018	BUY	$9.55 - $12.64 $291,933 - $386,392	30,569 New	30,569 $292,000

Others Institutions Holding VCYT

# of Institutions

254

Shares Held

82.1M

Call Options Held

42.3K

Put Options Held

18.2K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.42B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Veracyte, Inc. Transaction History